Impact Factor: 1.571 (2016) Circulation: The Publisher does not disclose the circulation. Aims of the journal: Ophthalmic Epidemiology publishes editorials, scientific articles, review articles, news notes, scientific notes, letter and book reviews on all subjects and topics related to ophthalmic epidemiology, public health and prevention of blindness. Ophthalmic Epidemiology has been the recipient of excellent epidemiologic articles from all over the world on a broad variety and range of topics, such as: incidence and prevalence studies, study design, screening program results, health care outcomes, cost benefit outcomes, biostatistical theories, quality of life studies, risk factor analysis and therapeutic outcomes as representative studies considered for publication. Content: Ophthalmic Epidemiology contains the following sections: Editorials Original articles Abstracts Brief notes Review articles Letters to the Editor Book reviews Announcements Manuscript submission: Author guidelines can be found here Online manuscripts submission at http://mc.manuscriptcentral.com/nope <w:LsdException Locked="false" UnhideWhenU

Serves as the official journal of the American Society of Ophthalmic Plastic and Reconstructive Surgery. Published for ophthalmologists, physicians, surgeons, and medical professionals who specialize in the eye. Articles provide reviews on topics such as ptosis, eyelid reconstruction, orbital diagnosis and surgery, lacrimal problems and eyelid malposition. Includes reports on diagnostic techniques, surgical equipment and medical therapies.

Designed as a peer-reviewed journal for ophthalmology clinicians. Includes clinical and basic research in areas of ophthalmology. Provides research findings and clinical trial information.

Healio's ophthalmology vertical.

Ophthalmology 360 provides timely and relevant summaries of important studies, critical presentation

Provides information on how to properly file claims for such services as removal of cataracts, echo exams, E/M, laser surgery, serial tonometry exams, and much more. Includes coding solutions for rightful reimbursement of services.

Designed for practicing ophthalmologists. Offers business information on managing a successful practice and includes coverage of case studies, reviews, personal finance issues, industry and economic trends, technology and techniques.

Peer-reviewed journal to provide opportunities for the free exchange of ideas and information amongst ophthalmologists.

Ophthalmology Times is a physician-driven publication that disseminates news and information of a clinical, socioeconomic, and political nature in a timely and accurate manner for members of the ophthalmic community.

Background and Format: Ophthalmology Times Europe is a physician-driven publication that disseminates news and information on clinical, social and political issues to members of the European ophthalmology community. In partnership with their readers, OTE is a forum for ophthalmologists to communicate their clinical knowledge, insights and discoveries, and through which to better understand management success strategies for improving and expanding their practices. OTE aims to cover all of the latest developments within the ophthalmic industry. With a broad focus on cataract, corneal and refractive surgery, glaucoma and vitreoretinal conditions, OTE reports on all major news, events, surgical and clinical developments and industry trends in Europe, providing a resource for time-pressured ophthalmologists throughout the European community. Audience and Readership: The magazine's readership includes ophthalmologists of all sub-specialities in all European countries, ophthalmologists who focus on teaching and research, residents and industry leaders. Time of Publication: January, March, April, May, June, August, September, October, November and December. Frequency: 10 issues a year, with double issues shipping Jan/Feb and Jul/Aug. Circulation: Source: publisher Monthly Unique Users: 5,000 (Source: publisher) Ad Rates: More information can be found in the media pack here.